Meet Abigail Caudle, M.D.
Abigail S. Caudle, M.D., M.S., F.A.C.S., CMQ
Department of Breast Surgical Oncology, Division of Surgery
Present Title & Affiliation
Primary Appointment
Vice President, Division of Procedural & Theraptc Prac, Ofc of Chief Operating Officer, The University of Texas MD Anderson Cancer Center, Houston, TX
Associate Professor, Department of Breast Surgical Oncology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX
Education & Training
Degree-Granting Education
| 2023 | Harvard University T.S Chan School of Public Health, Boston, MA, USA, MHCM, Masters of Health Care Management |
| 2013 | University of Michigan School of Public Health, Ann Arbor, MI, USA, MS, Clinical Research Design and Statistical Analysis |
| 2000 | University of North Carolina School of Medicine, Chapel Hill, NC, USA, MD, Medicine |
| 1995 | University of North Carolina, Chapel Hill, NC, USA, BS, Biology and Chemistry |
Postgraduate Training
| 2008-2009 | Research Fellowship, Surgical Oncology Research, NIH T-32 Training Grant, The University of Texas MD Anderson Cancer Center, Houston, TX |
| 2007-2010 | Clinical Fellowship, Surgical Oncology Fellow, The University of Texas MD Anderson Cancer Center, Houston, TX |
| 2005-2007 | Research Fellowship, Surgical Oncology, NIH T-32 Training Grant, University of North Carolina, Chapel Hill, NC |
| 2000-2005 | Clinical Residency, General Surgery, University of North Carolina, Chapel Hill, NC |
Board Certifications
| 2006 | American Board of Surgery |
Experience & Service
Academic Appointments
Assistant Professor, Department of Breast Surgical Oncology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, 2010 - 2016
Administrative Appointments/Responsibilities
Member, The University of Texas MD Anderson Cancer Center, Houston, TX, 2021 - Present
Vice President, The University of Texas MD Anderson Cancer Center, Houston, TX, 2020 - Present
Associate Vice President & Executive Medical Director, Department of Perioperative, The University of Texas MD Anderson Cancer Center, Houston, TX, 2019 - 2020
Program Coordinator, Breast Surgical Oncology Morbidity & Mortality Conference, Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2016 - Present
Breast Surgical Oncology Quality Officer, Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2014 - Present
Administrative Fellow, Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2008 - 2010
Administrative Chief Resident, University of North Carolina, Chapel Hill, NC, 2004 - 2005
Other Appointments/Responsibilities
Assistant Anatomy Clinical Liaison, University of North Carolina School of Medicine, Chapel Hill, NC, 2006 - 2007
Anatomy Course Teaching Assistant, University of North Carolina School of Medicine, Chapel Hill, NC, 2005 - 2007
Institutional Committee Activities
Member, COVID Core Leadership Team, 2020 - Present
Member, Accreditation Readiness Committee, 2019 - 2019
Member, Clinical Operations Leadership Team Steering Committee, 2018 - 2019
Member, Clinical Operations Leadership Team, 2018 - 2019
Member, Clinical Capital Equipment Committee, 2017 - Present
Committee Member, Division of Surgery T32 Steering Committee, 2016 - 2017
Committee Member, Integrated Clinical Practice Informatics Committee, 2016 - 2019
Member, Perioperative Informatics Committee, 2016 - Present
Committee Member, MD Anderson at Summit Relationship Committee, 2016 - 2019
Committee Member, Multi-Team Scheduling Task Force Committee, 2015 - 2017
Committee Member, Division of Surgery Gender Inclusiveness Committee, 2015 - 2023
Program Leader, Interdisciplinary Breast Cancer Fellowship, 2012 - 2015
Committee Member, Surgical Oncology Curriculum Task Force, 2011 - 2012
Committee Member, OR Block Utilization Task Force, 2011 - Present
Committee Member, Patient Care Task Force, 2011 - 2012
Committee Member, Surgical Oncology Education Committee, 2010 - Present
Member, Administrative Fellow, 2008 - 2010
Honors & Awards
| 2015 | MD Anderson Clinical Innovator Award, The University of Texas MD Anderson Cancer Center |
| 2015 | Best Poster Session, European Society of Gynecology Oncology |
| 2012 | US News & World Report Top Doctor |
| 2012 | Rising Star - www.SuperDoctors.com |
| 2007 | Translational Science Poster Award, Lineberger Comprehensive Cancer Center Scientific Retreat |
| 2003 | Outstanding Resident Award, Wake Medical Center, Raleigh, NC |
| 2000 | Academic Merit Award, University of North Carolina School of Medicine, Chapel Hill, NC |
| 1992 | North Carolina Merit Scholarship, University of North Carolina, Chapel Hill, NC |
Selected Publications
Peer-Reviewed Articles
- Tzeng CD, Teshome M, Katz MHG, Weinberg JS, Lai SY, Antonoff MB, Bird JE, Shafer A, Davis JW, Adelman DM, Moon B, Reece G, Prabhu SS, DeSnyder SM, Skibber JM, Mehran R, Schmeler K, Roland CL, Tran Cao HS, Aloia TA, Caudle AS, Swisher SG, Vauthey JN. Cancer Surgery Scheduling During and After the COVID-19 First Wave: The MD Anderson Cancer Center Experience. Ann Surg 272(2):e106-e111, 2020. PMID: 32675511.
- Schaverien MV, Kuerer HM, Caudle AS, Smith BD, Hwang RF, Robb GL. Outcomes of Volume Replacement Oncoplastic Breast-Conserving Surgery Using Chest Wall Perforator Flaps: Comparison with Volume Displacement Oncoplastic Surgery and Total Breast Reconstruction. Plast Reconstr Surg 146(1):14-27, 2020. PMID: 32590634.
- Deigni OA, Baumann DP, Adamson KA, Garvey PB, Selber JC, Caudle AS, Smith BD, Hanson SE, Robb GL, Schaverien MV. Immediate Contralateral Mastopexy/Breast Reduction for Symmetry Can Be Performed Safely in Oncoplastic Breast-Conserving Surgery. Plast Reconstr Surg 145(5):1134-1142, 2020. PMID: 32332525.
- Hwang ES, Hyslop T, Hendrix LH, Duong S, Bedrosian I, Price E, Caudle AS, Hieken T, Guenther J, Hudis CA, Winer E, Lyss AP, Dickson-Witmer D, Hoefer R, Ollila DW, Hardman T, Marks J, Chen YY, Krings G, Esserman L, Hylton N. Phase II Single-Arm Study of Preoperative Letrozole for Estrogen Receptor-Positive Postmenopausal Ductal Carcinoma In Situ: CALGB 40903 (Alliance). J Clin Oncol 38(12):1284-1292, 2020. e-Pub 2020. PMID: 32125937.
- Park KU, Kyrish K, Yi M, Bedrosian I, Caudle AS, Kuerer HM, Hunt KK, Miggins MV, DeSnyder SM. Opioid Use after Breast-Conserving Surgery: Prospective Evaluation of Risk Factors for High Opioid Use. Ann Surg Oncol. e-Pub 2019. PMID: 31820211.
- Weiss A, Lopez NE, Ward EP, Lee KC, Caudle AS, Dickson-Witmer D, Chang C, Kelly K, Martin LW, Jacobs LK, Hunt KK, Yao K, Blair SL. Challenges in Clinical Trial Implementation: Results from a Survey of the National Accreditation Program of Breast Centers (NAPBC). Ann Surg Oncol 26(13):4364-4371, 2019. e-Pub 2019. PMID: 31625045.
- Stecklein SR, Park M, Liu DD, Valle Goffin JJ, Caudle AS, Mittendorf EA, Barcenas CH, Mougalian S, Woodward WA, Valero V, Sahin AA, Yang WT, Shaitelman SF. Long-Term Impact of Regional Nodal Irradiation in Patients With Node-Positive Breast Cancer Treated With Neoadjuvant Systemic Therapy. Int J Radiat Oncol Biol Phys 102(3):568-577, 2018. e-Pub 2018. PMID: 29928946.
- Tevis SE, Neuman HB, Mittendorf EA, Kuerer HM, Bedrosian I, DeSnyder SM, Thompson AM, Black DM, Scoggins ME, Sahin AA, Hunt KK, Caudle AS. Multidisciplinary Intraoperative Assessment of Breast Specimens Reduces Number of Positive Margins. Ann Surg Oncol 25(10):2932-2938, 2018. e-Pub 2018. PMID: 29947001.
- Weiss A, Mittendorf EA, DeSnyder SM, Hwang RF, Bea V, Bedrosian I, Hoffman K, Adrade B, Sahin AA, Kuerer HM, Hunt KK, Caudle AS. Expanding Implementation of ACOSOG Z0011 in Surgeon Practice. Clin Breast Cancer 18(4):276-281, 2018. e-Pub 2017. PMID: 29100726.
- Van Wyhe RD, Caudle AS, Shaitelman SF, Perkins GH, Buchholz TA, Hoffman KE, Strom EA, Smith BD, Tereffe W, Woodward WA, Stauder MC. A component of lobular carcinoma in clinically lymph node-negative patients predicts for an increased likelihood of upstaging to pathologic stage III breast cancer. Adv Radiat Oncol 3(3):252-257, 2018. e-Pub 2018. PMID: 30197937.
- Kuerer HM, Rauch GM, Krishnamurthy S, Adrada BE, Caudle AS, DeSnyder SM, Black DM, Santiago L, Hobbs BP, Lucci A, Gilcrease M, Hwang RF, Candelaria RP, Chavez-MacGregor M, Smith BD, Arribas E, Moseley T, Teshome M, Miggins MV, Valero V, Hunt KK, Yang WT. A Clinical Feasibility Trial for Identification of Exceptional Responders in Whom Breast Cancer Surgery Can Be Eliminated Following Neoadjuvant Systemic Therapy. Ann Surg 267(5):946-951, 2018. PMID: 28549010.
- Caudle AS, Bedrosian I, Milton DR, DeSnyder SM, Kuerer HM, Hunt KK, Mittendorf EA. Use of Sentinel Lymph Node Dissection After Neoadjuvant Chemotherapy in Patients with Node-Positive Breast Cancer at Diagnosis: Practice Patterns of American Society of Breast Surgeons Members. Ann Surg Oncol 24(10):2925-2934, 2017. e-Pub 2017. PMID: 28766207.
- Tadros AB, Yang WT, Krishnamurthy S, Rauch GM, Smith BD, Valero V, Black DM, Lucci A, Caudle AS, DeSnyder SM, Teshome M, Barcenas CH, Miggins M, Adrada BE, Moseley T, Hwang RF, Hunt KK, Kuerer HM. Identification of Patients With Documented Pathologic Complete Response in the Breast After Neoadjuvant Chemotherapy for Omission of Axillary Surgery. JAMA Surg 152(7):665-670, 2017. PMID: 28423171.
- FitzSullivan E, Bassett RL, Kuerer HM, Mittendorf EA, Yi M, Hunt KK, Babiera GV, Caudle AS, Black DM, Bedrosian I, Reyna C, Teshome M, Meric-Bernstam F, Hwang R. Outcomes of Sentinel Lymph Node-Positive Breast Cancer Patients Treated with Mastectomy Without Axillary Therapy. Ann Surg Oncol 24(3):652-659, 2017. e-Pub 2016. PMID: 27822630.
- Sandberg LJ, Clemens MW, Symmans WF, Valero V, Caudle AS, Smith B, Kuerer HM, Hsu L, Kronowitz SJ. Molecular Profiling Using Breast Cancer Subtype to Plan for Breast Reconstruction. Plast Reconstr Surg 139(3):586e-596e, 2017. PMID: 28234813.
- Smith BD, Jiang J, Shih YC, Giordano SH, Huo J, Jagsi R, Momoh AO, Caudle AS, Hunt KK, Shaitelman SF, Buchholz TA, Shirvani SM. Cost and Complications of Local Therapies for Early-Stage Breast Cancer. J Natl Cancer Inst 109(1), 2017. e-Pub 2016. PMID: 27678203.
- Shaitelman SF, Stauder MC, Allen P, Reddy S, Lakoski S, Atkinson B, Reddy J, Amaya D, Guerra W, Ueno N, Caudle A, Tereffe W, Woodward WA. Impact of Statin Use on Outcomes in Triple Negative Breast Cancer. J Cancer 8(11):2026-2032, 2017. e-Pub 2017. PMID: 28819403.
- Shin K, Caudle AS, Kuerer HM, Santiago L, Candelaria RP, Dogan B, Leung J, Krishnamurthy S, Yang W. Radiologic Mapping for Targeted Axillary Dissection: Needle Biopsy to Excision. AJR Am J Roentgenol 207(6):1372-1379, 2016. e-Pub 2016. PMID: 27726422.
- Stauder MC, Caudle AS, Allen PK, Shaitelman SF, Smith BD, Hoffman KE, Buchholz TA, Chavez-Macgregor M, Hunt KK, Meric-Bernstam F, Woodward WA. Outcomes of Post Mastectomy Radiation Therapy in Patients Receiving Axillary Lymph Node Dissection After Positive Sentinel Lymph Node Biopsy. Int J Radiat Oncol Biol Phys 96(3):637-44, 2016. e-Pub 2016. PMID: 27681760.
- Carter SA, Lyons GR, Kuerer HM, Bassett RL, Oates S, Thompson A, Caudle AS, Mittendorf EA, Bedrosian I, Lucci A, DeSnyder SM, Babiera G, Yi M, Baumann DP, Clemens MW, Garvey PB, Hunt KK, Hwang RF. Operative and Oncologic Outcomes in 9861 Patients with Operable Breast Cancer: Single-Institution Analysis of Breast Conservation with Oncoplastic Reconstruction. Ann Surg Oncol 23(10):3190-8, 2016. e-Pub 2016. PMID: 27406093.
- Vila J, Mittendorf EA, Farante G, Bassett RL, Veronesi P, Galimberti V, Peradze N, Stauder MC, Chavez-MacGregor M, Litton JF, Huo L, Kuerer HM, Hunt KK, Caudle AS. Nomograms for Predicting Axillary Response to Neoadjuvant Chemotherapy in Clinically Node-Positive Patients with Breast Cancer. Ann Surg Oncol 23(11):3501-9, 2016. e-Pub 2016. PMID: 27216742.
- Sanford RA, Lei X, Barcenas CH, Mittendorf EA, Caudle AS, Valero V, Tripathy D, Giordano SH, Chavez-MacGregor M. Impact of Time from Completion of Neoadjuvant Chemotherapy to Surgery on Survival Outcomes in Breast Cancer Patients. Ann Surg Oncol 23(5):1515-21, 2016. e-Pub 2015. PMID: 26678405.
- Caudle AS, Yang WT, Krishnamurthy S, Mittendorf EA, Black DM, Gilcrease MZ, Bedrosian I, Hobbs BP, DeSnyder SM, Hwang RF, Adrada BE, Shaitelman SF, Chavez-MacGregor M, Smith BD, Candelaria RP, Babiera GV, Dogan BE, Santiago L, Hunt KK, Kuerer HM. Improved Axillary Evaluation Following Neoadjuvant Therapy for Patients With Node-Positive Breast Cancer Using Selective Evaluation of Clipped Nodes: Implementation of Targeted Axillary Dissection. J Clin Oncol 34(10):1072-8, 2016. e-Pub 2016. PMID: 26811528.
- Swisher SK, Vila J, Tucker SL, Bedrosian I, Shaitelman SF, Litton JK, Smith BD, Caudle AS, Kuerer HM, Mittendorf EA. Locoregional Control According to Breast Cancer Subtype and Response to Neoadjuvant Chemotherapy in Breast Cancer Patients Undergoing Breast-conserving Therapy. Ann Surg Oncol 23(3):749-56, 2016. e-Pub 2015. PMID: 26511263.
- Rauch GM, Hobbs BP, Kuerer HM, Scoggins ME, Benveniste AP, Park YM, Caudle AS, Fox PS, Smith BD, Adrada BE, Krishnamurthy S, Yang WT. Microcalcifications in 1657 Patients with Pure Ductal Carcinoma in Situ of the Breast: Correlation with Clinical, Histopathologic, Biologic Features, and Local Recurrence. Ann Surg Oncol 23(2):482-9, 2016. e-Pub 2015. PMID: 26416712.
- Kim BJ, Caudle AS, Gottumukkala V, Aloia TA. The Impact of Postoperative Complications on a Timely Return to Intended Oncologic Therapy (RIOT): The Role of Enhanced Recovery in the Cancer Journey. Int Anesthesiol Clin 54(4):e33-46, 2016. PMID: 27623128.
- Francis AM, Haugen CE, Grimes LM, Crow JR, Yi M, Mittendorf EA, Bedrosian I, Caudle AS, Babiera GV, Krishnamurthy S, Kuerer HM, Hunt KK. Is Sentinel Lymph Node Dissection Warranted for Patients with a Diagnosis of Ductal Carcinoma In Situ?. Ann Surg Oncol 22(13):4270-9, 2015. e-Pub 2015. PMID: 25905585.
- Shaitelman SF, Tereffe W, Dogan BE, Hess KR, Caudle AS, Valero V, Stauder MC, Krishnamurthy S, Candelaria RP, Strom EA, Woodward WA, Hunt KK, Buchholz TA, Whitman GJ. Role of Ultrasonography of Regional Nodal Basins in Staging Triple-Negative Breast Cancer and Implications For Local-Regional Treatment. Int J Radiat Oncol Biol Phys 93(1):102-10, 2015. e-Pub 2015. PMID: 26279028.
- Caudle AS, Yang WT, Mittendorf EA, Black DM, Hwang R, Hobbs B, Hunt KK, Krishnamurthy S, Kuerer HM. Selective surgical localization of axillary lymph nodes containing metastases in patients with breast cancer: a prospective feasibility trial. JAMA Surg 150(2):137-43, 2015. PMID: 25517573.
- Caudle AS, Kuerer HM, Le-Petross HT, Yang W, Yi M, Bedrosian I, Krishnamurthy S, Fornage BD, Hunt KK, Mittendorf EA. Predicting the extent of nodal disease in early-stage breast cancer. Ann Surg Oncol 21(11):3440-7, 2014. e-Pub 2014. PMID: 24859939.
- Xiang DB, Wei B, Abraham SC, Huo L, Albarracin CT, Zhang H, Babiera G, Caudle AS, Akay CL, Rao P, Zhao YJ, Lu X, Wu Y. Molecular cytogenetic characterization of mammary neuroendocrine carcinoma. Hum Pathol 45(9):1951-6, 2014. e-Pub 2014. PMID: 25074542.
- Mittendorf EA, Caudle AS, Yang W, Krishnamurthy S, Shaitelman S, Chavez-MacGregor M, Woodward WA, Bedrosian I, Kuerer HM, Hunt KK. Implementation of the american college of surgeons oncology group z1071 trial data in clinical practice: is there a way forward for sentinel lymph node dissection in clinically node-positive breast cancer patients treated with neoadjuvant chemotherapy?. Ann Surg Oncol 21(8):2468-73, 2014. e-Pub 2014. PMID: 24841348.
- Haynes AB, Bloom ES, Bedrosian I, Kuerer HM, Hwang RF, Munsell MF, Chemaly RF, Graviss LS, Caudle AS, Hunt KK, Tereffe W, Shaitelman SF, Babiera GV. Timing of infectious complications following breast-conserving therapy with catheter-based accelerated partial breast irradiation. Ann Surg Oncol 21(8):2512-6, 2014. e-Pub 2014. PMID: 24736987.
- MacDermond DM, Houtman KM, Thang SH, Allen PK, Caudle AS, Gainer SM, Hunt KK, Perkins GH, Shaitelman SF, Smith BD, Strom EA, Tereffe W, Woodward WA, Buchholz TA, Hoffman KE. Therapeutic radiation dose delivered to the low axilla during whole breast radiation therapy in the prone position: Implications for targeting the undissected axilla. Pract Radiat Oncol 4(2):116-22, 2014. e-Pub 2013. PMID: 24890352.
- Caudle AS, Yi M, Hoffman KE, Mittendorf EA, Babiera GV, Hwang RF, Meric-Bernstam F, Sahin AA, Hunt KK. Impact of identification of internal mammary sentinel lymph node metastasis in breast cancer patients. Ann Surg Oncol 21(1):60-5, 2014. e-Pub 2013. PMID: 24046126.
- Wang J, Mittendorf EA, Sahin AA, Min Y, Caudle AS, Hunt KK, Wu Y. Outcomes of sentinel lymph node dissection alone verses axillary lymph node dissection in early stage invasive lobular carcinoma: A retrospective study of the Surveillance, Epidemiology, and End Results (SEER) Database. PLoS One 9(2):e89778, 2014. PMID: 24587029.
- Fitzsullivan E, Lari SA, Smith B, Caudle AS, Krishnamurthy S, Lucci A, Mittendorf EA, Babiera GV, Black DM, Wagner JL, Bedrosian I, Woodward W, Gainer SM, Hwang R, Meric-Bernstam F, Hunt KK, Kuerer HM. Incidence and consequence of close margins in patients with ductal carcinoma-in situ treated with mastectomy: is further therapy warranted?. Ann Surg Oncol 20(13):4103-12, 2013. e-Pub 2013. PMID: 23975313.
- Yi M, Kuerer HM, Mittendorf EA, Hwang RF, Caudle AS, Bedrosian I, Meric-Bernstam F, Wagner JL, Hunt KK. Impact of the American College of Surgeons Oncology Group Z0011 criteria applied to a contemporary patient population. J Am Coll Surg 216(1):105-13, 2013. e-Pub 2012. PMID: 23122536.
- Alvarado R, Lari SA, Roses RE, Smith BD, Yang W, Mittendorf EA, Arun BK, Lucci A, Babiera GV, Wagner JL, Caudle AS, Meric-Bernstam F, Hwang RF, Bedrosian I, Hunt KK, Kuerer HM. Biology, Treatment, and Outcome in Very Young and Older Women with DCIS. Ann Surg Oncol 19(12):3777-84, 2012. e-Pub 2012. PMID: 22622473.
- Alvarado R, Yi M, Le-Petross H, Gilcrease M, Mittendorf EA, Bedrosian I, Hwang RF, Caudle AS, Babiera GV, Akins JS, Kuerer HM, Hunt KK. The role for sentinel lymph node biopsy after neoadjuvant chemotherapy in patients who present with node-positive breast cancer. Ann Surg Oncol 19(10):3177-84, 2012. e-Pub 2012. PMID: 22772869.
- Gainer SM, Hunt KK, Beitsch P, Caudle AS, Mittendorf EA, Lucci A. Changing behavior in clinical practice in response to the ACOSOG Z0011 Trial: A survey of the American Society of Breast Surgeons. Ann Surg Oncol 19(10):3152-8, 2012. e-Pub 2012. PMID: 22820938.
- Caudle AS, Hunt KK, Tucker SL, Hoffman K, Gainer SM, Lucci A, Kuerer HM, Meric-Bernstam F, Shah R, Babiera GV, Sahin AA, Mittendorf EA. American College of Surgeons Oncology Group (ACOSOG) Z0011: Impact on surgeon practice patterns. Ann Surg Oncol 19(10):3144-51, 2012. e-Pub 2012. PMID: 22847123.
- Kuerer HM, Lari SA, Arun BK, Hu CY, Brewster A, Mittendorf EA, Albarracin CT, Babiera GV, Caudle AS, Wagner JL, Litton JK, Bedrosian I, Meric-Bernstam F, Lucci A, Hunt KK. Biologic features and prognosis of ductal carcinoma in situ are not adversely impacted by initial large body mass. Breast Cancer Res Treat 133(3):1131-41, 2012. e-Pub 2012. PMID: 22392043.
- Caudle AS, Yu TK, Tucker SL, Bedrosian I, Litton JK, Gonzalez-Angulo AM, Hoffman K, Meric-Bernstam F, Hunt KK, Buchholz TA, Mittendorf EA. Local-regional control according to surrogate markers of breast cancer subtypes and response to neoadjuvant chemotherapy in breast cancer patients undergoing breast conserving therapy. Breast Cancer Res 14(3):R83, 2012. e-Pub 2012. PMID: 22621334.
- Caudle AS, Hunt KK, Kuerer HM, Meric-Bernstam F, Lucci A, Bedrosian I, Babiera GV, Hwang RF, Ross MI, Feig BW, Hoffman K, Litton JK, Sahin AA, Yang W, Hortobagyi GN, Buchholz TA, Mittendorf EA. Multidisciplinary considerations in the implementation of the findings from the american college of surgeons oncology group (ACOSOG) Z0011 Study: A Practice-Changing Trial. Ann Surg Oncol 18(9):2407-12, 2011. e-Pub 2011. PMID: 21327455.
- Caudle AS, Gonzalez-Angulo AM, Hunt KK, Pusztai L, Kuerer HM, Mittendorf EA, Hortobagyi GN, Meric-Bernstam F. Impact of progression during neoadjuvant chemotherapy on surgical management of breast cancer. Ann Surg Oncol 18(4):932-8, 2011. e-Pub 2010. PMID: 21061075.
- Poindexter NJ, Williams RR, Powis G, Jen E, Caudle AS, Chada S, Grimm EA. IL-24 is expressed during wound repair and inhibits TGFalpha-induced migration and proliferation of keratinocytes. Exp Dermatol 19(8):714-22, 2010. PMID: 20545760.
- Caudle AS, Gonzalez-Angulo AM, Hunt KK, Liu P, Pusztai L, Symmans WF, Kuerer HM, Mittendorf EA, Hortobagyi GN, Meric-Bernstam F. Predictors of tumor progression during neoadjuvant chemotherapy in breast cancer. J Clin Oncol 28(11):1821-8, 2010. e-Pub 2010. PMID: 20231683.
- Kiser M, Caudle AS, von Allmen D. Multicentric paragangliomas associated with Carney triad. Am Surg 76(2):216-8, 2010. PMID: 20336905.
- Beasley GM, Caudle AS, Petersen RP, McMahon NS, Padussis J, Mosca PJ, Zager JS, Hochwald SN, Grobmyer SR, Delman KA, Andtbacka RH, Noyes RD, Kane JM, Seigler H, Pruitt SK, Ross MI, Tyler DS. A multi-institutional experience of isolated limb infusion: defining response and toxicity in the US. J Am Coll Surg 208(5):706-15; discussion 715-7, 2009. e-Pub 2009. PMID: 19476821.
- Caudle AS, Kim HJ, Tepper JE, O'Neil BH, Lange LA, Goldberg RM, Bernard SA, Calvo BF, Meyers MO. Diabetes mellitus affects response to neoadjuvant chemoradiotherapy in the management of rectal cancer. Ann Surg Oncol 15(7):1931-6, 2008. e-Pub 2008. PMID: 18418656.
- Caudle AS, Tepper JE, Calvo BF, Meyers MO, Goyal LK, Cance WG, Kim HJ. Complications associated with neoadjuvant radiotherapy in the multidisciplinary treatment of retroperitoneal sarcomas. Ann Surg Oncol 14(2):577-82, 2007. e-Pub 2006. PMID: 17119868.
- Caudle AS, Brier SE, Calvo BF, Kim HJ, Meyers MO, Ollila DW. Experienced radio-guided surgery teams can successfully perform minimally invasive radio-guided parathyroidectomy without intraoperative parathyroid hormone assays. Am Surg 72(9):785-9; discussion 790, 2006. PMID: 16986387.
- Ollila DW, Caudle AS, Cance WG, Kim HJ, Cusack JC, Swasey JE, Calvo BF. Successful minimally invasive parathyroidectomy for primary hyperparathyroidism without using intraoperative parathyroid hormone assays. Am J Surg 191(1):52-6, 2006. PMID: 16399106.
Invited Articles
- Park KU, Caudle A. Management of the Axilla in the Patient with Breast Cancer. Surg Clin North Am 98(4):747-760, 2018. e-Pub 2018. PMID: 30005771.
- Kim BJ, Caudle AS, Gottumukkala V, Aloia TA. The Impact of Postoperative Complications on a Timely Return to Intended Oncologic Therapy (RIOT): The Role of Enhanced Recovery in the Cancer Journey. Int Anesthesiol Clin 54(4), 2016. PMID: 27623128.
- Caudle AS, Kuerer HM. Targeting and limiting surgery for patients with node-positive breast cancer. BMC-Medicine 13(1):149, 2015. PMID: 26109042.
- Caudle AS, Thompson AM. Less Remains Better: Morbidity After Axillary Surgery. Ann Surg Oncol 22(1):4-6, 2015. e-Pub 2014. PMID: 25047480.
- Caudle AS, Kuerer HM. Breast Conservation Therapy After Neoadjuvant Chemotherapy: Optimization of a Multimodality Approach. J Surg Oncol 110(1):32-6, 2014. e-Pub 2014. PMID: 24623334.
- Caudle AS, Cupp JA, Kuerer HM. Management of Axillary Disease. Surg Oncol Clin N Am 23(3):473-486, 2014. e-Pub 2014. PMID: 24882346.
- Caudle AS. Commentary on: Breast-Conserving therapy achieves locoregional outcomes comparable to mastectomy in women with T1-2N0 triple-negative breast cancer. Breast Diseases: A Year Book Quarterly 25(1), 2014.
- Caudle AS. Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Patients with Cytologically Proven Node-Positive Breast Cancer at Diagnosis. Breast Diseases: A Year Book Quarterly 25(3), 2014.
- Caudle AS. Is Nipple-Sparing Mastectomy a Safe Oncologic Procedure?. Breast Diseases:A Year Book Quarterly 23(3), 2013.
- Caudle AS. Commentary on: Rare breast cancer: 933 adenoid cystic carcinomas from the national cancer data base. Breast Diseases: A Year Book Quarterly 24(4), 2013.
- Caudle AS. Is there a role for sentinel lymph node dissection in patients with ductal carcinoma in situ?. Breast Diseases: A Year Book Quarterly 23(1), 2012.
- Caudle AS,HM Kuerer. Large national cooperative group trial examines survival endpoint associated with breast cancer occult metastases. J Watch Oncol and Hematol, 2012.
- Caudle AS. Does blue dye contribute to success of sentinel node mapping for breast cancer. Breast Diseases:A Year Book Quarterly 22(3), 2011.
- Caudle AS, Hunt KK. The neoadjuvant approach in breast cancer treatment: it is not just about chemotherapy anymore. Curr Opin Obstet Gynecol 23(1):31-6, 2011. PMID: 21124221.
- Caudle AS, Ross MI. Metastasectomy for Stage IV Melanoma: For Whom and How Much?. Surg Oncol Clin N Am 20(1):133-44, 2011. PMID: 21111963.
- Ollila DW, Caudle AS. Surgical management of distant metastases. Surg Oncol Clin N Am 15(2):385-98, 2006. PMID: 16632222.
Abstracts
- Caudle AS, Yang WT, Krishnamurthy S, Mittendorf EA, Bedrosian I, Hunt K, Kuerer HM. Factors impacting the accuracy of targeted axillary dissection. Ann Surg Oncol 24 (Suppl 1): Abstract 14, 2017.
- Tadros A, Yang WT, Krishnamurthy S, Rauch G, Smith B, Valero V, Black DM, Caudle AS, Lucci A, DeSnyder S, Teshome M, Barcenas C, Miggins M, Moseley T, Adrada B, Hwang R, Hunt KK, Kuerer HM. Eliminating axillary surgery in exceptional responders to neoadjuvant chemotherapy with documented pathologic complete response in the breast. Ann Surg Oncol 24 (Suppl 1): Abstract 15, 2017.
- Caudle AS, Bedrosian I, Milton DR, DeSnyder SM, Kuerer HM, Hunt KK, Mittendorf EA. The use of sentinel lymph node dissection after neoadjuvant chemotherapy in clinically node positive patients: Practice patterns of members of the American Society of Breast Surgeons. American Society of Breast Surgeons 2017 Annual Meeting Official Proceedings Abstract 257239 (Volume XVII):28, 2017.
- Weiss A, Mittendorf EA, DeSnyder SM, Hwang R, Bedrosian I, Hoffman K, Adrada BE, Bea V, Sahin AA, Kuerer HM, Hunt KK, Caudle AS. ACOSOG Z0011: Impact after 5 years. American Society of Breast Surgeons 2017 Annual Meeting Official Proceedings Abstract 256764 (Volume XVII):168, 2017.
- Weiss A, Kuerer HM, Yang WT, Krishnamurthy S, DeSnyder SM, Black DM, Babiera GV, Teshome T, Hunt KK, Caudle AS. Potential for targeted axillary dissection in patients who do not receive neoadjuvant chemotherapy. American Society of Breast Surgeons 2017 Annual Meeting Official Proceedings Abstract 257320 (Volume XVII):163, 2017.
- Smith BD, Jiang J, Shih YT, Giordano SH, Jagsi R, Caudle AS, Hunt KK, Buchholz TA, Shirvani SM. Complication and cost burden of local therapy options for early breast cancer. Cancer Res 76 (Suppl 4) S3-07, 2016.
- Alvarez RH, Koenig KB, Ensor J, Ibrahim NK, Chavez MacGregor M, Litton JK, Schwartz Gomez J, Cyriac A, Krishnamurthy S, Caudle AS, Shaitelman SF, Whitman GJ, Murray JL, Booser DJ, Reuben JM, Valero V. A randomized phase II neoadjuvant study of sequential eribulin followed by FAC/FEC-regimen compared to sequential paclitaxel followed by FAC/FEC-regimen in patients with operable breast cancer not expressing HER2. Cancer Res 76 (Suppl 4) P1-14-04, 2016.
- Ross MI, Bedrosian I, Black BM, Mittendorf EA, Caudle AS, Babiera GV, Hwang R, Meric-Bernstam F, Grisson CB, Brulotte M, Andtbacka RHI. A Phase I clinical trial of VST-1001 (dilute fluorescein) in lymphatic mapping and sentinel lymph node localization in clinically node negative breast cancer. Cancer Res 76 (Supp 4) P3-01-09, 2016.
- Caudle AS, Fleming J, Garcia BM, Lozano M, Rigby D, Manuel-Byrd R, McMillian L, Avalos C, Hodge R, Butler C, Hunt KK, Baumann BP. Optimizing surgical instrument sets for cases involving breast and plastic surgeons. J Clin Oncol 34 (Suppl 7S): Abstract 33, 2016.
- Yi M, Mittendorf EA, Bedrosian I, Black DM, Kuerer HM, DeSnyder SM, Caudle AS, Babiera GV, Hunt KK. Sentinel lymph node dissection in patients with multicentric invasive breast cancer. Ann Surg Onc 20 (Suppl 1): P60, 2016.
- Black DM, Wagner J, Mittendorf EA, Hwang RF, DeSnyder SM, Yang WT, Rohren E, Kuerer HM, Hunt KK, Caudle AS. Implementing a radioactive see localization program in breast cancer surgery: A multidisciplinary approach. Ann Surg Oncol 22 (Suppl 1) Abstract P97, 2015.
- Sauder CAM, Stauder M, Hunt KK, Lucci A, Mittendorf EA, Whitman GJ, Kuerer HM, Caudle AS. Outcomes with contralateral axillary nodal metastases in breast cancer. Ann Surg Oncol 22 (Suppl 1) Abstract P63, 2015.
- Caudle AS, Yang WT, Mittendorf EA, Black DM, Gilcrease M, Bedrosian I, Hobbs BP, Canderlaria RP, Babiera GV, Dogan BE, Lim MJ, Santiago L, Hunt KK, Krishnamurthy S, Kuerer HM. Targeted axillary dissection improves axillary evaluation following neoadjuvant chemotherapy in node positive patients. Ann Surg Oncol 22 (Suppl 1) Abstract S2, 2015.
- Sanford RA, Barcenas CH, Caudle AS, Giordano SH, Lei X, Mittendorf EA, Tripathy D, Vicente V, Chaves MacGregor M. Impact of neoadjuvant chemotherapy to surgery interval; on survival outcomes in breast cancer patients. J Clin Oncol 22 (Suppl 1) Abstract 1063, 2015.
- Boland G, Caudle AS, Prieto V, Curry JL, Cormier JN, Royal RE, Lee JE, Werneke CL, Ross MI, Gershenwald J. Predictors of survival in contemporary era patients with thin melanoma who underwent sentinel node biopsy. Ann Surg Oncol 21 (Suppl 1: S23) Abstract 53, 2014.
- Caudle AS, Yang W, Mittendorf EA, Black DM, Gilcrease M, Bedrosian I, Hobbs BP, Canderlaria RP, Babiera GV, Dogan BE, Santiago L, Hunt KK, Krishnamurthy S, Kuerer HM. Improved axillary evaluation following neoadjuvant chemotherapy for node positive patients with image-guided surgery. J Clin Oncol 32 (Suppl 26) Abstract 99, 2014.
- Caudle AS, Kuerer HM, Le-Petross HT, Yang W, Bedrosian I, Krishnamurthy S, Lucci A, Hunt KK, Mittendorf EA. Predicting the extent of nodal disease in early breast cancer. J Clin Oncol 31 (Suppl 26) Abstract 95, 2013.
- Alvarado R, Lari SA, Roses RE, Smith BD, Yang W, Mittendorf EA, Arun BK, Lucci A, Babiera GV, Wagner JL, Caudle AS, Meric-Bernstam F, Hwang RF, Bedrosian I, Hunt KK, Kuerer HM. Biology, Treatment, and Outcome in Very Young and Older Women with DCIS. Ann Surg Oncol 17 (Suppl 1)(s58):46. e-Pub 2012. PMID: 22622473.
- Alvarado R, Yi M, Le-Petross H, Gilcrease M, Mittendorf EA, Bedrosian I, Hwang RF, Caudle AS, Babiera GV, Akins JS, Kuerer HM, Hunt KK. The role for sentinel lymph node biopsy after neoadjuvant chemotherapy in patients who present with node-positive breast cancer. American Society of Breast Surgeons Official Proceedings, 2012. PMID: 22772869.
- Gainer SM, Hunt KK, Beitsch P, Caudle AS, Mittendorf EA, Lucci A. Changing behavior in clinical practice in response to the ACOSOG Z0011 Trial: A survey of the American Society of Breast Surgeons. Ann Surg Oncol Abstract 0072, 2012. PMID: 22820938.
- Caudle AS, Hunt KK, Tucker SL, Hoffman K, Gainer SM, Lucci A, Kuerer HM, Meric-Bernstam F, Shah R, Babiera GV, Sahin AA, Mittendorf EA. American College of Surgeons Oncology Group (ACOSOG) Z0011: Impact on surgeon practice patterns. American Society of Breast Surgeons Official Proceedings Abstract 168, 2012.
- Caudle AS, Min Y, Mittendorf EA, Babiera GV, Hwang RF, Meric-Bernstam F, Sahin. The identification of internal mammary sentinel lymph node metastasis impacts therapy in breast cancer. American Society of Breast Surgeons Official Proceedings Abstract 0072, 2012.
- Dallas NA, Yi M, Hunt KK, Shah R, Kuerer HM, Litton JK, Wu Y, Caudle AS, Meric-Bernstam F, Sahin AA, Mittendorf EA. Evaluation of the stage IB designation of the 7th Edition of the AJCC Staging System: Receptor status and nuclear grade are better survival discriminants than presence of micrometastases. J Clin Oncol 30(Suppl), 2012.
- Caudle AS, Ross MI, Prieto VG, Warneke CL, Lee JE, Johnson MM, Gardner JL, Royal RE, Cormier JN, Lucci A, Gershenwald JE. Mitotic rate predicts sentinel node involvement in melanoma: Impact of the 7th edition AJCC melanoma staging system. Ann Surg Oncol 17(Suppl 1):S8, 2010.
- Smith MB, Caudle AS, Caskey LS, Meyers MO, Moore DT, Calvo BF. Epiregulin mRNA expression in colorectal hepatic metastases is associated with survival post partial hepatectomy. Ann Surg Oncol 17(Suppl 1):S24, 2010.
- Caudle AS, Gonzalez-Angulo AM, Hunt KK, Pusztai L, Kuerer HM, Mittendorf EA, Hortobagyi GN, Meric-Bernstam F. Impact of Progression during Neoadjuvant Chemotherapy on Operative Management of Breast Cancer. Cancer Research 69(24):567s, 2009.
- Caudle AS, Gonzalez-Angulo A, Hunt KK, Ping L, Pusztai L, Symman F, Kuerer H, Mittendorf EA, Hortobagyi G, Meric-Bernstam F. Predictors of tumor progression during neoadjuvant chemotherapy in breast cancer. J Clin Oncol 27:15s, 2009.
- Caudle AS, Poindexter N, Grimm EA. Differential regulation of EGFR by IL-24 in human melanoma cells and melanocytes. Proc 100th Ann Mtg of AACR, 2009.
- Yeh JJ, Caudle AS, McPhail L, Sigel CS, Caskey L, Routh ED, Kim HJ, Meyers MO, Calvo BF. A molecular signature of clinical risk in patients with colorectal liver metastasis. Ann Surg Oncol 16(S1):S17, 2009.
- Sommer CA, Calvo BF, Caudle AS, Yeh JJ, Frank JS, Ollila DW. Multiple strategies to ensure a successful minimally invasive parathyroidectomy. Ann Surg Oncol 16(Suppl 2):51, 2009.
- Caudle AS, Willborn K, Abdalla EK, Evans DB, Vauthey JN, Ellis LM, Yao JC. Feasibility of synchronous resection of primary and metastatic. Ann Surg Oncol 15(S2):51, 2008.
- Caudle AS, Caskey LS, Earp HS, Calvo BF. Increased amphiregulin and epiregulin expression in colorectal tumors may explain clinical response to EGFR-targeted antibody therapy. Ann Surg Oncol 14(Suppl 2), 2007.
- Caudle AS, Rubinas TC, Caskey LS, Earp HS, Calvo BF. Measuring the epidermal growth factor receptor and its ligands in paraffin-embedded archived patient samples. ASCO GI Symposium;Orlando, FL, 2007.
- Caudle AS, Caskey LS, Earp HS, Calvo BF. Colorectal adenocarcinomas have increased EGFR ligand expression. J Am Coll Surg 203(3):S87, 2006.
- Caudle AS, Calvo BF, Kim HJ, Bernard S, Tepper JE, O’Neil BH, Meyers MO. Diabetes decreases response to neoadjuvant therapy in rectal cancer. Ann Surg Oncol 13(S1), 2006.
- Caudle AS, Calvo BF, Meyers MO, Cance WG, Goyal LK, Tepper JE, Kim HJ. Preoperative radiotherapy in the multidisciplinary treatment of retroperitoneal sarcomas. Ann Surg Oncol 12(Suppl), 2005.
- Ollila DW, Caudle AS, Cance WG, Kim HJ, Cusack JC, Swasey JE, Calvo BF. Successful minimally invasive parathyroidectomy without intra-operative parathyroid hormone assay. Ann Surg Oncol 11(Suppl 2):S119, 2004.
Book Chapters
- Le-Petross HT, Caudle AS. Breast Cancer Screening and Diagnosis. In: Staging of Breast Cancer. Shetty MK, ed. Springer: Media, PA, 2015.
- Caudle AS, Delman KA, Cormier JN. Sarcoma: Soft Tissue Sarcoma, Bone Sarcoma. In: The M.D. Anderson Surgical Oncology Handbook,. 5th. Lippincott Williams, & Wilkins: Philadelphia, PA, 2012.
- Caudle AS, Babiera GV. Surgical Management of Disseminated Breast Cancer. In: Advanced Therapy of Breast Disease. 3rd. People’s Publishing House: Shelton, CT, 2012.
- Caudle AS, Babiera GV. Management of Recurrent and Disseminated Breast Cancer. In: Cameron’s Current Surgical Therapy. 10th. Elsevier: New York, 952-956, 2011.
- Caudle AS, Mittendorf EA, Kuerer HM. Lymphatic Mapping and Sentinel Lymphatic Mapping and Sentinel Lymph Node Biopsy. In: Elective General Surgery: An Evidence-Based Approach. People's Medical Publishing House: New York, 2011.
- Caudle AS, Ollila DW. Surgical Resection of Distant Metastases: Rationale, Indications, and Results. In: Advanced Therapy in Surgical Oncology. BC Decker Hamilton: Ontario, 2008.
- Caudle AS, Kim HJ, Tepper JE. Evidence-based Practice: The Role of Adjuvant Radiotherapy in the Treatment of Gastric Adenocarcinoma. In: Gastrointestinal Oncology: Evidence and Analysis. Marcel Dekker: New York, 2005.
Letters to the Editor
- Caudle AS, Hunt KK, Mittendorf EA. Response to the Letter to the Editor: Multidisciplinary considerations in the implementation of the findings from the American College of Surgeons Oncology Group (ACOSOG) Z0011 Study: A practice-changing trial. Ann Surg Oncol 18 Suppl 3: 283, 2011.
- Caudle AS, Gonzalez-Angulo AM, Meric-Bernstam F. Response to Letter to the Editor: Strategy for non-responder breast cancer patients to neoadjuvant treatment. Ann Surg Oncol 18 Suppl 3: 288-9, 2011.
Grant & Contract Support
| Title: | T32-Training Grant |
| Funding Source: | NIH |
| Role: | Trainee |
| Title: | T32 Training Grant |
| Funding Source: | NIH/NCI |
| Role: | Trainee |
| Title: | Targeted Axillary Dissection - A Novel Surgical Approach to Accurately Assess Response to Preoperative Chemotherapy in Clinical Node Positive Breast Cancer Patients |
| Funding Source: | Institutional Clinical Innovator Award Application |
| Role: | Principal Investigator |
| Title: | Targeted Axillary Dissection: A Novel Surgical Approach to Accurately Assess Response to Preoperative Chemotherapy in Clinically Node Positive Breast Cancer Patients |
| Funding Source: | Mike Hogg Foundation Award |
| Role: | Principal Investigator |
| Title: | Co-Targeting the LncRNA-PIP3 Interaction and AKT/PI3K Signaling Axis: A Novel Paradigm for treating Triple-Negative Breast Cancer |
| Funding Source: | Department of Defense (DOD) |
| Role: | Co-Investigator |
| Title: | Comparative Effectiveness Research on Cancer in Texas (CERCIT) 2.0: Project 3 |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | Co-Investigator |
| Title: | A Prospective Open Label Study of Use of Magseed and Sentimag to Localize Axillary Lymph Nodes with Biopsy- proven Metastases in Breast Cancer Patients |
| Funding Source: | MDACC High Impact Clinical Research Support Program (HI-CRSP) |
| Role: | Principal Investigator |
| Title: | Co-Targeting the LncRNA-PIP3 Interaction and AKT/PI3K Signaling Axis: A Novel Paradigm for treating Triple-negative Breast Cancer |
| Funding Source: | NIH/NCI |
| Role: | Collaborator |
Patient Reviews
CV information above last modified September 18, 2024